旅遊\航空\酒店\餐飲等經濟復甦概念股集體上漲 最新版新冠診療方案提病例實施分類收治
格隆匯3月16日丨今日港A兩地市場旅遊、航空、酒店、餐飲等經濟復甦概念股集體上漲。A股旅遊股中,眾信旅遊、曲江文旅、凱撒旅業和嶺南控股漲停;航空股中中國國航漲停,中國東航、南方航空、吉祥航空和白雲機場均漲超5%;酒店餐飲股中,華天酒店、西安旅遊逼近漲停。港股航空股中,美蘭空港和中國國航漲超8%,南方航空和東方航空漲超4%;餐飲股中,海倫司漲14%,九毛九、百勝中國漲超8%,旅遊股中,攜程漲超12%,同程旅遊漲超10%,香港中旅漲近4%。國家衞健委昨日發佈《新型冠狀病毒肺炎診療方案(試行第九版)》,其中提出,對病例實施分類收治。根據各地反映的“奧密克戎變異毒株患者以無症狀感染者和輕型病例為主,大多不需要過多治療,全部收治到定點醫院會佔用大量醫療資源”等意見,進一步完善了病例分類收治措施:輕型病例實行集中隔離管理,相關集中隔離場所不能同時隔離入境人員、密切接觸者等人羣。隔離管理期間應做好對症治療和病情監測,如病情加重,應轉至定點醫院治療。普通型、重型、危重型病例和有重型高危因素的病例應在定點醫院集中治療,其中重型、危重型病例應當儘早收入ICU治療,有高危因素且有重症傾向的患者也宜收入ICU治療。



Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.